Skip to main content
. 2018 May 23;9:259. doi: 10.3389/fendo.2018.00259

Table 1.

Main characteristics and findings of key studies examined the relation between VDBP and pregnancy-related clinical outcomes.

Study ID First author, year (reference) Included subjects Investigated outcome(s) Key findings
1 Sørensen, 2016 (39) 113 pregnant women whose offspring later developed T1D/220 pregnant controls VDBP concentrations during pregnancy and subsequent risk for T1D development in the offspring Lower third trimester VDBP concentrations associated with higher risk of T1D in the offspring

2 Wang, 2015 (40) 692 women with GDM/802 pregnant controls Whether Vitamin D related SNPs predispose to GDM development rs3733359 allele-A was correlated with an increased GDM risk, in the obese subgroup

3 Kolialexi, 2017 (44) 5 pregnant women with EOPE/5 pregnant controls Identification of potential biomarkers for EOPE VDBP in the first trimester was upregulated to 3.38-fold in the EOPE group

4 Mekbeb, 1990 (45) 107 pregnant women with PE/132 pregnant controls Relation between GC phenotype and PE risk Gc 2-1 phenotype was expressed significantly in PE group compared to controls

5 Powe, 2010 (46) 39 pregnant women with PE/131 pregnant controls Relation between first trimester VDBP levels and subsequent PE risk No association between VDBP concentrations, subsequent PE development and first trimester BP

6 Cleal, 2015 (33) 85 pregnant women Relation between maternal VDBP levels and placental expression of genes related to placental amino acid transport VDBP levels were positively associated with placental expression of specific genes involved in amino acid transport

7 Wookey, 2017 (49) Placentae from 18 pregnant women with FGR/17 gestation-matched healthy control subjects Whether VDBP expression is altered in FGR-associated placental dysfunction Significant reduction of placental VDBP concentrations in women with idiopathic FGR compared to controls

8 Liong, 2015 (50) 12 pregnant women with preterm delivery/129 women as validation cohort Identification of CVF biomarkers predictive of spontaneous preterm birth in women with symptoms of preterm labor Albumin/VDBP ratio is more efficacious than fetal fibronectin in predicting spontaneous preterm delivery in symptomatic women within 7 days

9 Liong, 2013 (52) 5 pregnant women with PROM/10 gestation-age matched controls Identification of differentially expressed proteins in the CVF of asymptomatic women before the clinical manifestation of preterm PROM VDBP was significantly increased (3.9-fold) in the PROM group

10 Tannetta, 2014 (47) 10 non-pregnant women/10 women with normal pregnancy/10 women with EOPE/10 women with LOPE Investigation of the actin scavenging system in PE Actin-free VDBP plasma levels were lower in EOPE compared to normal pregnancies, still not statistically significantly

11 Szczepańska, 2015 (61) 154 women with endometriosis-associated infertility/347 controls Identification of genetic risk factors for endometriosis-associated infertility Genotype distribution of GC rs1155563 and rs2298849 SNPs did not differ between patients and controls

12 Behrouz, 2013 (48) 5 human placentas from normotensive pregnant women/sera from 20 normal and 20 women with severe PE Investigation of placental proteins as targets for auto-antibodies in PE patients VDBP of placental origin is a target for auto-antibodies detected in sera of women with PE

13 Chun, 2017 (53) Maternal and umbilical cord blood from 356 pregnant women and their infants Relation between maternal GC SNPs, 25(OH)D concentrations and infant birth weight Low 25(OH)D concentrations in the maternal and cord blood were significantly associated with decreased birth weight among infants of mothers carrying the rs12512631 ‘C’ allele

14 Moon, 2017 (54) 682 pregnant women (351 placebo, 331 cholecalciferol) Relation between GC SNPs and the response to gestational cholecalciferol supplementation GC rs2282679 positively correlated with achieved 25(OH)D status

15 Baca, 2018 (55) 882 Black and 1796 White pregnant women Relationship between maternal vitamin D receptor, GC, and CYP27B1 SNPs and 25(OH)D concentrations The minor allele for rs7041 was related to increased 25(OH)D and rs4588 was associated with decreased 25(OH)D levels

16 Shao, 2017 (56) 759 pregnant women Relationship between vitamin D pathway genes, gene–environment interactions, and vitamin D levels Gc-1f and Gc-1s genotypes had higher plasma 25(OH)D levels compared to women with Gc-2 genotype

17 Ganz, 2018 (57) 26 third-trimester pregnant/28 lactating/21 non-pregnant and non-lactating women consuming a single amount of vitamin D Metabolic effects of GC rs7041 SNP on vitamin D biomarkers Increased VDBP concentrations were observed only in pregnant women with GG or GT genotypes

18 Park, 2016 (58) 26 healthy pregnant/28 lactating/21 non-pregnant and non-lactating women consuming a single amount of vitamin D The impact of the reproductive state on vitamin D biomarkers Higher VDBP concentrations were observed in healthy pregnant women compared to non-pregnant controls

19 Doneray, 2018 (59) 30 mother-neonate pairs with serum 25(OH)D < 10 ng/ml/30 mother–neonate pairs with serum 25(OH)D > 20 ng/ml Relationship between serum 25(OH)D and VDBP levels in mother-neonate pairs The maternal and neonatal vitamin D concentrations were negatively correlated with their VDBP concentrations

20 Franasiak, 2017 (60) 39 infertile premenopausal women/29 regularly cycling fertile controls Differences in VDBP concentrations between fertile and infertile women VDBP concentrations were lower in the infertile group, compared to controls

21 Karras, 2018 (43) 70 pairs of newly delivered neonates and their mothers Relationship between vitamin D, VDBP, and the adipokines, adiponectin, and irisin in mothers and neonates at birth and their effects on neonate anthropometric outcomes Independent positive correlation of maternal VDBP levels with adiponectin and irisin concentrations. Strong association of VDBP and adiponectin but not irisin was found in neonates

VDBP, Vitamin D-binding protein; T1D, type 1 diabetes; GDM, gestational diabetes mellitus; SNP, single nucleotide polymorphism; PE, preeclamsia; EOPE, early onset preeclampsia; LOPE, late onset preeclampsia; Gc, group-specific component; BP, blood pressure; FGR, fetal growth restriction; CVF, cervicovaginal fluid; PROM, preterm premature rupture of the fetal membranes; 25(OH)D, 25-hydroxyvitaminn D.